A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors
Clinical trial NCT05781360 · TERMINATED
Trial details
- NCT number
- NCT05781360
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-05-25
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.